Haematologica
(Oct 2022)
Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant
- George Chen,
- Megan Herr,
- Jan Nowak,
- Christine Ho,
- Nikolaos Almyroudis,
- Kristopher Attwood,
- John Bonnewell,
- Marissa Walsh,
- Brahm Segal,
- Maureen Ross,
- Philip McCarthy,
- Theresa Hahn
Affiliations
- George Chen
- Department of Medicine, Transplant and Cellular Therapy Program
- Megan Herr
- Department of Medicine, Transplant and Cellular Therapy Program
- Jan Nowak
- Department of Pathology
- Christine Ho
- Department of Medicine, Transplant and Cellular Therapy Program
- Nikolaos Almyroudis
- Department of Internal Medicine, Division of Infectious Diseases
- Kristopher Attwood
- Department of Biostatistics
- John Bonnewell
- Department of Internal Medicine, Division of Infectious Diseases
- Marissa Walsh
- Department of Internal Medicine, Division of Infectious Diseases
- Brahm Segal
- Department of Internal Medicine, Division of Infectious Diseases
- Maureen Ross
- Department of Medicine, Transplant and Cellular Therapy Program
- Philip McCarthy
- Department of Medicine, Transplant and Cellular Therapy Program
- Theresa Hahn
- Department of Cancer Prevention and Control
- DOI
-
https://doi.org/10.3324/haematol.2022.281719
- Journal volume & issue
-
Vol. 108,
no. 2
WeChat QR code
